Filing Details

Accession Number:
0001628280-21-003854
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-03 16:17:42
Reporting Period:
2021-03-01
Accepted Time:
2021-03-03 16:17:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1793294 Ppd Inc. PPD Services-Commercial Physical & Biological Research (8731) 453806427
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1802057 Michael David Johnston C/O Ppd, Inc.
929 North Front Street
Wilmington NC
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-01 21,597 $10.59 74,704 No 4 M Direct
Common Stock Disposition 2021-03-01 39,297 $35.43 35,407 No 4 S Direct
Common Stock Acquisiton 2021-03-02 21,597 $10.59 57,004 No 4 M Direct
Common Stock Disposition 2021-03-02 21,597 $36.29 35,407 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-03-01 21,597 $0.00 21,597 $10.59
Common Stock Stock Option (Right to Buy) Disposition 2021-03-02 21,597 $0.00 21,597 $10.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
245,883 2027-05-11 No 4 M Direct
224,286 2027-05-11 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.07 to $35.72, inclusive. The reporting person undertakes to provide to PPD, Inc. (the "Issuer"), any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. Represents 46,519 vested stock options and 199,364 unvested stock options which are eligible to vest upon the achievement of certain return on capital or rate of return conditions three years after the initial public offering of the Issuer or earlier, upon certain sales by significant stockholders. Does not include an additional 33,227 stock options with an exercise price of $10.59 which are eligible to vest upon the achievement of certain EBITDA-based vesting conditions for fiscal year 2021.
  5. Represents 24,922 vested stock options and 199,364 unvested stock options which are eligible to vest upon the achievement of certain return on capital or rate of return conditions three years after the initial public offering of the Issuer or earlier, upon certain sales by significant stockholders. Does not include an additional 33,227 stock options with an exercise price of $10.59 which are eligible to vest upon the achievement of certain EBITDA-based vesting conditions for fiscal year 2021.